… head and neck squamous cell carcinoma (HNSCC) will recur. The treatment of patients with
… Areas covered: This article will comprehensively review the current systemic treatment of R/…

With the advent of targeted antiangiogenic therapies for renal cell carcinoma (RCC), the
prognosis for patients with locally advanced or metastatic disease has significantly improved. …

… non-adherence to current treatment guidelines, restrictions in … Metastatic renal cell carcinoma
(mRCC) is a malignancy with … , treatment can be clinically and economically optimized in …

… The outcome of patients with metastatic renal cell carcinoma … to help practicing oncologists
optimize patient outcomes. This … , and treat the side effects of treatment and optimize patient …

… systemic treatment options for metastatic renal cell carcinoma … poor-risk category) as treatments
for clear-cell mRCC, while … Among second-line treatment options, everolimus alone has …

… new treatments for metastatic renal cell carcinoma comes the … in metastatic renal cell
carcinoma has been gathered from … agents to treat metastatic renal cell carcinoma, assesses the …

Sequencing decisions in advanced renal cell carcinoma are likely to become more difficult
when new targeted agents are approved for first and subsequent lines of therapy. …

… Anti-angiogenic treatment is an important option that has changed the therapeutic landscape
in various tumors, particularly in patients affected by renal cell carcinoma (RCC). Agents …

… effects that could result in dose decrease, treatment interruption, or discontinuation would
provide an important additional means of optimizing treatment selection. To that end, Faber et …

… of care for treating metastatic renal cell carcinoma is sequential … with metastatic renal cell
carcinoma. Cancer Metastasis … Optimizing treatment of metastatic renal cell carcinoma by …